Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine
International Journal of Drug Delivery Technology · 19.05.2026 · 16 (30s)
DOI: 10.25258/ijddt.16.30s.32 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 19.05.2026. Verfasst von Mo Zaid Ajmeri und 2 weiteren Autor:innen.
Abstract (Originalsprache)
The present study aimed to develop and characterize oral disintegrating films (ODFs) of Zotepine, a poorly water-soluble atypical antipsychotic drug, to enhance its solubility, dissolution rate, and bioavailability. Zotepine exhibits limited aqueous solubility and undergoes extensive first-pass metabolism, which restricts its therapeutic effectiveness. To overcome these limitations, β-cyclodextrin inclusion complexation was employed as a solubility enhancement technique. Preformulation studies, including melting point determination and UV spectrophotometric analysis, confirmed the identity and purity of the drug. The observed melting point (87–92 °C) and λmax at 235 nm validated the authenticity of Zotepine, while compatibility studies indicated no significant drug–excipient interactions. Inclusion complexes were prepared and demonstrated a significant improvement in solubility and drug release compared to the pure drug. These complexes were further incorporated into ODFs using suitable film-forming polymers and plasticizers. A 3² factorial design was applied to optimize formulation variables, and the prepared films were evaluated for physicochemical and mechanical properties. Among all formulations, batch ZF3 exhibited optimal performance, showing rapid disintegration (~20 seconds) and maximum drug release (~99% within 12 minutes). Statistical analysis confirmed excellent model fitting with high correlation coefficients (R² ≈ 0.999). Accelerated stability studies revealed no significant changes in formulation characteristics, confirming stability
Zitieren
APA
Ajmeri, M. Z., Taretiya, K. D., & Bhangale, J. O. (2026). Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine. International Journal of Drug Delivery Technology, 16(30s). https://doi.org/10.25258/ijddt.16.30s.32
Vancouver
Ajmeri MZ, Taretiya KD, Bhangale JO. Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine. International Journal of Drug Delivery Technology. 2026;16(30s). doi:10.25258/ijddt.16.30s.32
BibTeX
@article{Ajmeri2026,
author = {Ajmeri, Mo Zaid and Taretiya, Krishna D. and Bhangale, Jitendra O.},
title = {Development and Characterization of Oral Disintegrating Films Incorporated with Inclusion Complex of Zotepine},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {30s},
doi = {10.25258/ijddt.16.30s.32}
}
EUVIMED